Cannara Announces Grant of Options and RSUs
Rhea-AI Summary
Cannara Biotech (OTCQB: LOVFF), a vertically integrated cannabis producer with two mega facilities in Québec totaling over 1,650,000 sq. ft., has announced new incentive awards following its fiscal year-end on August 31, 2025.
The company granted 3,625,000 stock options to employees at an exercise price of $1.44 per share, vesting monthly over three years with a ten-year expiration. Additionally, 145,000 restricted share units (RSUs) were awarded to board members, vesting fully after two years. The announcement comes after five consecutive years of revenue growth in their cannabis operations.
Positive
- Five consecutive years of year-over-year revenue growth
- Comprehensive employee and director incentive program implemented
- Large-scale operations with two mega facilities totaling 1,650,000 sq. ft.
Negative
- Potential dilution from 3,770,000 new shares through options and RSUs
News Market Reaction – LOVFF
In the trading session that priced this news, LOVFF declined 3.72%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at disruptive prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced that its board of directors has approved the grant of incentive awards under the Company’s stock option plan (the “Stock Option Plan”), and restricted share unit compensation plan (the “RSU Plan”) (collectively, the “Incentive Plans”).
The awards were granted aligning with the completion of the Company’s fiscal year-end on August 31, 2025, which marked five consecutive years of commercial operations and year-over-year revenue growth since launching its cannabis business.
In accordance with and subject to the terms of the Incentive Plans and the applicable requirements of the TSX Venture Exchange (the “TSXV”), the Company has granted, effective August 28, 2025:
- 3,625,000 stock options to certain employees of the Company. Each stock option is exercisable into one common share of the Company at an exercise price of
$1.44 per share, will vest in equal monthly installments over a period of three (3) years, and will expire ten (10) years from the date of grant. - 145,000 restricted share units (RSUs) to members of the board of directors. Each RSU entitles the holder to receive one common share of the Company without additional consideration and will vest in full on the second anniversary of the date of grant.
The grants are subject to the terms of the Incentive Plans and the applicable requirements of the TSXV.
CONTACT
| Nicholas Sosiak, CPA, CA Chief Financial Officer nick@cannara.ca | Zohar Krivorot President & Chief Executive Officer zohar@cannara.ca |
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
ABOUT CANNARA
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), is a vertically integrated producer of affordable premium-grade cannabis products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca.
